VDR and breast cancer: Another study within the MDCS cohort showed that patients with invasive tumors expressing a high fraction of nuclear VDR had a relatively low breast cancer-specific mortality, i.e., a good survival, and were associated with favorable tumor characteristics, such as ER expression [12].